Positive Minimal Residual Disease By Multiparameter Flow Cytometry in 9 Months after Autologous Stem Cell Transplantation and High-Risk Cytogenetics Predict Poor Outcome in Multiple Myeloma

被引：0
|
作者：
Huang, Beihui
Li, Juan
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4532
引用
收藏
页数：2
相关论文
共 50 条
  • [1] High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma
    Paiva, Bruno
    Gutierrez, Norma C.
    Rosinol, Laura
    Vidriales, Maria-Belen
    Montalban, Maria-Angeles
    Martinez-Lopez, Joaquin
    Mateos, Maria-Victoria
    Cibeira, Maria-Teresa
    Cordon, Lourdes
    Oriol, Albert
    Terol, Maria-Jose
    Echeveste, Maria-Asuncion
    de Paz, Raquel
    de Arriba, Felipe
    Palomera, Luis
    de la Rubia, Javier
    Diaz-Mediavilla, Joaquin
    Sureda, Anna
    Gorosquieta, Ana
    Alegre, Adrian
    Martin, Alejandro
    Hernandez, Miguel T.
    Lahuerta, Juan-Jose
    Blade, Joan
    San Migue, Jesus F.
    BLOOD, 2012, 119 (03) : 687 - 691
  • [2] High-Risk Cytogenetics and Persistent Minimal Residual Disease (MRD) by Multiparameter Flow Cytometry (MFC) Predict Unsustained Complete Response (CR) After Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)
    Paiva, Bruno
    Gutierrez, Norma C.
    Rosinol, Laura
    Vidriales, Maria-Belen
    Montalban, Maria-Angeles
    Martinez-Lopez, Joaquin
    Victoria Mateos, Maria
    Teresa Cibeira, Maria
    Courdon, Lourdes
    Oriol, Albert
    Jose Terol, Maria
    Echebeste, Maria-Asuncion
    de Paz, Raquel
    de Arriba, Felipe
    Palomera, Luis
    De La Rubia, Javier
    Diaz-Mediavilla, Joaquin
    Sureda, Anna
    Gorosquieta, Ana
    Alegre, Adrian
    Martin, Alejandro
    Hernandez, Miguel T.
    Jose Lahuerta, Juan
    Blade, Joan
    San Miguel, Jesus F.
    BLOOD, 2011, 118 (21) : 287 - 288
  • [3] Prognostic Significance of Minimal Residual Disease Testing by Multiparameter Flow Cytometry in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
    Mostafa, Nevine
    El-Salakawy, Walaa
    Abdelbary, Haitham
    Radwan, Rania
    Fathy, Rasha
    Abouelmagd, Yasmin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S300 - S300
  • [4] MINIMAL RESIDUAL DISEASE BY MULTIPARAMETRIC FLOW CYTOMETRY IS A USEFUL APPROACH TO IDENTIFY PATIENTS AT DIFFERENT RISK OF PROGRESSION AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
    Stoyanov, P.
    Ganeva, P.
    Dikov, T.
    Michova, A.
    Tonev, I.
    Garcheva, L.
    Balatzenko, G.
    Arnaudov, G.
    Michaylov, G.
    Guenova, M.
    HAEMATOLOGICA, 2012, 97 : 106 - 106
  • [5] Post-transplant minimal residual disease by multiparameter flow cytometry strongly correlates with long-term outcome of patients with multiple myeloma undergoing autologous haematopoietic stem cell transplantation
    Taboada, F.
    Fanjul, E.
    Carrera, D.
    Gonzalez, A. J.
    Gonzalez, A. P.
    Palomo, P.
    Colado, E.
    Gonzalez, S.
    Rayon, C.
    Vallejo, C.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S259 - S260
  • [6] Multiparameter Flow Cytometry For Detection Of Minimal Residual Disease In Multiple Myeloma After T-Cell Depleted Allogeneic Stem Cell Transplant
    Kosuri, Satyajit
    Smith, Katherine M.
    Kuk, Deborah
    Devlin, Sean M.
    Maslak, Peter G.
    Giralt, Sergio
    Koehne, Guenther
    BLOOD, 2013, 122 (21) : 4647 - 4649
  • [7] Do Cytogenetics Predict Likelihood to Attain Minimal Residual Disease (MRD) Post Autologous Stem Cell Transplantation (SCT) in Multiple Myeloma (MM)?
    Jain, Tania
    Guerrero, Carlo
    Kosiorek, Heidi
    Butterfield, Richard
    Mountjoy, Luke
    Reeder, Craig
    Bergsagel, P. Leif
    Larsen, Jeremy T.
    Stewart, Keith
    Fonseca, Rafael
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [8] Monitoring of minimal residual disease among multiple myeloma patients after autologous stem cell transplantation
    Akhundova, F.
    Mendeleeva, L.
    Galtseva, I.
    Pokrovskaya, O.
    Urnova, E.
    Parovichnikova, E.
    Savchenko, V.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S258 - S259
  • [9] Multiple myeloma: Maintenance therapy after autologous stem cell transplantation, depending on minimal residual disease
    Solovyev, M. V.
    Mendeleeva, L. P.
    Pokrovskaya, O. S.
    Nareyko, M. V.
    Firsova, M. V.
    Galtseva, I. V.
    Davydova, Yu. O.
    Kapranov, N. M.
    Kuzmina, L. A.
    Gemdzhian, E. G.
    Savchenko, V. G.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (07) : 25 - 31
  • [10] Deferring autologous stem cell transplantation for consolidation of minimal residual disease in multiple myeloma
    Braunstein, Marc
    Niesvizky, Ruben
    SEMINARS IN ONCOLOGY, 2016, 43 (06) : 709 - 711
12345